Emgality (galcanezumab) 120 mg — United Healthcare
Preventive treatment of migraines
Initial criteria
- Diagnosis of migraines
- Used for the preventive treatment of migraines
- Medication will not be used in combination with another CGRP antagonist or inhibitor used for the preventive treatment of migraines (e.g., Nurtec ODT, Qulipta, Vyepti)
Reauthorization criteria
- Patient has experienced a positive response to therapy, demonstrated by a reduction in headache frequency and/or intensity
- Medication will not be used in combination with another CGRP antagonist or inhibitor used for the preventive treatment of migraines (e.g., Nurtec ODT, Qulipta, Vyepti)
Approval duration
12 months